Literature DB >> 21837549

The relationship between clinical and pathological variables in Richardson's syndrome.

Emma C Schofield1, John R Hodges, Thomas H Bak, John H Xuereb, Glenda M Halliday.   

Abstract

In order to determine the relationship between regional neuropathology and severity of clinical features in Richardson's syndrome (PSP-RS), the following hypotheses were tested: (1) executive dysfunction relates to prefrontal pathology; (2) language difficulties to pathology in Broca's area and/or the perirhinal cortex; and (3) visuospatial impairment to pathology in the supramarginal region. A prospectively studied case series of brain donors at a specialist clinic in Addenbrooke's Hospital Cambridge, UK, were examined. All those fulfilling postmortem criteria for PSP-RS and their last cognitive assessment within 24 months of death (N = 11/25) were included. The degree of regional neuronal loss and neuronal tau deposition across a number of cortical brain regions was performed and compared to 10 age- and sex-matched controls from the Sydney Brain Bank. Stepwise multiple linear regressions were used to determine the neuropathological correlates to cognitive scores and revealed the following. Executive dysfunction, as indexed by letter fluency, related to the degree of tau deposition in the superior frontal gyrus and supramarginal cortices (p < 0.020), language deficits related to neuron loss in the perirhinal gyrus (p < 0.001) and tau deposition in Broca's area (p = 0.020), while visuospatial dysfunction and global cognitive impairment related to tau deposition in the supramarginal gyrus (p < 0.007). The severity of cognitive deficits relate to regional cortical tau deposition in PSP-RS, although language impairment related to neuronal loss in the perirhinal region. Global cognitive dysfunction related most to the severity of tau deposition in the supramarginal gyrus warranting further research on the role of this brain region in PSP-RS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21837549     DOI: 10.1007/s00415-011-6205-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  41 in total

1.  Monitoring cognitive changes: psychometric properties of six cognitive tests.

Authors:  Chris M Bird; Kyriaki Papadopoulou; Paola Ricciardelli; Martin N Rossor; Lisa Cipolotti
Journal:  Br J Clin Psychol       Date:  2004-06

2.  Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

Authors:  N J Cordato; A J Duggins; G M Halliday; J G L Morris; C Pantelis
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

3.  Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.

Authors:  Kurt A Jellinger
Journal:  Neurodegener Dis       Date:  2008-03-18       Impact factor: 2.977

4.  The neural basis of semantic memory: evidence from semantic dementia.

Authors:  R Rhys Davies; Glenda M Halliday; John H Xuereb; Jillian J Kril; John R Hodges
Journal:  Neurobiol Aging       Date:  2008-03-25       Impact factor: 4.673

5.  Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.

Authors:  C Bergeron; M S Pollanen; L Weyer; A E Lang
Journal:  J Neuropathol Exp Neurol       Date:  1997-06       Impact factor: 3.685

6.  Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy.

Authors:  N J Cordato; C Pantelis; G M Halliday; D Velakoulis; S J Wood; G W Stuart; J Currie; M Soo; G Olivieri; G A Broe; J G L Morris
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

7.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy.

Authors:  T Esmonde; E Giles; M Gibson; J R Hodges
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

8.  Neurons in anterior cingulate cortex multiplex information about reward and action.

Authors:  Benjamin Y Hayden; Michael L Platt
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

9.  Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.

Authors:  P R Hof; A Delacourte; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Emotion recognition in progressive supranuclear palsy.

Authors:  B C P Ghosh; J B Rowe; A J Calder; J R Hodges; T H Bak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10       Impact factor: 10.154

View more
  10 in total

1.  Language boosting by transcranial stimulation in progressive supranuclear palsy.

Authors:  Antoni Valero-Cabré; Clara Sanches; Juliette Godard; Oriane Fracchia; Bruno Dubois; Richard Levy; Dennis Q Truong; Marom Bikson; Marc Teichmann
Journal:  Neurology       Date:  2019-07-03       Impact factor: 9.910

2.  Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis.

Authors:  Eleonora Del Prete; Luca Tommasini; Sonia Mazzucchi; Daniela Frosini; Giovanni Palermo; Riccardo Morganti; Cristina Pagni; Gloria Tognoni; Ubaldo Bonuccelli; Roberto Ceravolo
Journal:  Neurol Sci       Date:  2020-08-27       Impact factor: 3.307

3.  Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.

Authors:  Dana Wagshal; Sethu Sankaranarayanan; Valerie Guss; Tracey Hall; Flora Berisha; Iryna Lobach; Anna Karydas; Lisa Voltarelli; Carole Scherling; Hilary Heuer; Maria Carmela Tartaglia; Zachary Miller; Giovanni Coppola; Michael Ahlijanian; Holly Soares; Joel H Kramer; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Jere Meredith; Adam L Boxer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-06-04       Impact factor: 10.154

4.  Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model.

Authors:  Theresa N T Dang; Carol Dobson-Stone; Elias N Glaros; Woojin S Kim; Marianne Hallupp; Lauren Bartley; Olivier Piguet; John R Hodges; Glenda M Halliday; Kay L Double; Peter R Schofield; Peter J Crouch; John B J Kwok
Journal:  Dis Model Mech       Date:  2013-06-20       Impact factor: 5.758

5.  Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.

Authors:  Thomas E Cope; Timothy Rittman; Robin J Borchert; P Simon Jones; Deniz Vatansever; Kieren Allinson; Luca Passamonti; Patricia Vazquez Rodriguez; W Richard Bevan-Jones; John T O'Brien; James B Rowe
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

6.  Distribution patterns of tau pathology in progressive supranuclear palsy.

Authors:  Gabor G Kovacs; Milica Jecmenica Lukic; David J Irwin; Thomas Arzberger; Gesine Respondek; Edward B Lee; David Coughlin; Armin Giese; Murray Grossman; Carolin Kurz; Corey T McMillan; Ellen Gelpi; Yaroslau Compta; John C van Swieten; Laura Donker Laat; Claire Troakes; Safa Al-Sarraj; John L Robinson; Sigrun Roeber; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Günter U Höglinger
Journal:  Acta Neuropathol       Date:  2020-05-07       Impact factor: 17.088

7.  Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?

Authors:  Javier Sánchez-Ruiz de Gordoa; Victoria Zelaya; Paula Tellechea-Aramburo; Blanca Acha; Miren Roldán; Carlos López-Molina; Valle Coca; Arkaitz Galbete; Maite Mendioroz; M Elena Erro
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

8.  Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6.

Authors:  Valeria Isella; Daniele Licciardo; Francesca Ferri; Cinzia Crivellaro; Sabrina Morzenti; Ildebrando Appollonio; Carlo Ferrarese
Journal:  Front Aging Neurosci       Date:  2022-09-08       Impact factor: 5.702

Review 9.  Language impairment in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Katie A Peterson; Karalyn Patterson; James B Rowe
Journal:  J Neurol       Date:  2019-07-18       Impact factor: 4.849

10.  In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies.

Authors:  Elijah Mak; Negin Holland; P Simon Jones; George Savulich; Audrey Low; Maura Malpetti; Sanne S Kaalund; Luca Passamonti; Timothy Rittman; Rafael Romero-Garcia; Roido Manavaki; Guy B Williams; Young T Hong; Tim D Fryer; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  Neurobiol Aging       Date:  2021-01-30       Impact factor: 4.673

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.